Entry |
|
Name |
Pegdinetanib (USAN/INN) |
Formula |
C468H729N125O139S
|
Exact mass |
10356.3539
|
Mol weight |
10362.62
|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
Efficacy |
Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor |
Comment |
PEGylated peptide
angiogenesis inhibitor
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D09945 Pegdinetanib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
VEGFR family
VEGFR2 (KDR)
D09945 Pegdinetanib (USAN/INN)
|
Other DBs |
|
LinkDB |
|